Cargando…

The Predictability of Cystatin C for Peripheral Arterial Disease in Chinese Population with Type 2 Diabetes Mellitus

OBJECTIVES: Peripheral artery disease (PAD) in diabetic populations is a vital chronic disease all over the world due to its high morbidity and mortality. It is important to find early simple screening biomarkers and find residual risk factors that may provide a new target for prevention and treatme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Luna, Wang, Hai, Ning, Jing, Han, Junming, Yu, Chunxiao, Guan, Qingbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983175/ https://www.ncbi.nlm.nih.gov/pubmed/35392484 http://dx.doi.org/10.1155/2022/5064264

Ejemplares similares

To Compare the Level of Cystatin C in Type 2 Diabetes Mellitus with Obesity
por: Jhatta, Chahat, et al.
Publicado: (2020)

Correlation between the levels of serum cystatin C and substance P in peripheral blood in diabetes mellitus patients complicated with hypertension
por: Zhu, Wei, et al.
Publicado: (2018)

Urinary Cystatin C Has Prognostic Value in Peripheral Artery Disease
por: Li, Ben, et al.
Publicado: (2022)

Elevated Serum Cystatin C and Decreased Cathepsin S/Cystatin C Ratio Are Associated with Severe Peripheral Arterial Disease and Polyvascular Involvement
por: Nagy, Előd Ernő, et al.
Publicado: (2022)

Correlation Between Gut Microbiota and Testosterone in Male Patients With Type 2 Diabetes Mellitus
por: Liu, Shuang, et al.
Publicado: (2022)

Association of circulating cystatin C levels with type 2 diabetes mellitus: a systematic review and meta-analysis
por: Ma, Cheng-Cheng, et al.
Publicado: (2019)

Dyslipidemia and serum cystatin C levels as biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus
por: Dejenie, Tadesse Asmamaw, et al.
Publicado: (2023)

β2‐Microglobulin, Cystatin C, and Creatinine and Risk of Symptomatic Peripheral Artery Disease
por: Joosten, Michel M., et al.
Publicado: (2014)

Diagnostic Accuracy of Serum Cystatin C for Early Recognition of Nephropathy in Type 2 Diabetes Mellitus
por: Sapkota, Suman, et al.
Publicado: (2021)

Creatinine-to-cystatin C ratio as a marker of sarcopenia for identifying osteoporosis in male patients with type 2 diabetes mellitus
por: Dai, Huifan, et al.
Publicado: (2022)

Cystatin C: A Strong Marker for Lower Limb Ischemia in Chinese Type 2 Diabetic Patients?
por: Liu, Fang, et al.
Publicado: (2013)

Association between the ratio of serum creatinine to cystatin C and bone mineral density in Chinese older adults patients with type 2 diabetes mellitus
por: Gao, Ting, et al.
Publicado: (2022)

Relationship between High Serum Cystatin C Levels and the Risk of Gestational Diabetes Mellitus
por: Zhao, Weijing, et al.
Publicado: (2016)

Serum Cystatin C and Tubular Urinary Enzymes as Biomarkers of Renal Dysfunction in Type 2 Diabetes Mellitus
por: Assal, Heba S., et al.
Publicado: (2013)

Association between Serum Cystatin C and Vascular Complications in Type 2 Diabetes Mellitus without Nephropathy
por: Kim, Hye Jeong, et al.
Publicado: (2018)

Cystatin C Is an Important Biomarker for Cardiovascular Autonomic Dysfunction in Chinese Type 2 Diabetic Patients
por: Yang, Xubin, et al.
Publicado: (2019)

Correction: Creatinine‑to‑cystatin C ratio as a marker of sarcopenia for identifying osteoporosis in male patients with type 2 diabetes mellitus
por: Dai, Huifang, et al.
Publicado: (2022)

Serum Cystatin C as a Biomarker for Predicting Coronary Artery Disease in Diabetes
por: Oh, Jee-Young
Publicado: (2010)

Prognostic value of creatinine-to-cystatin c ratio in patients with type 2 diabetes mellitus: a cohort study
por: Wei, Wen, et al.
Publicado: (2022)

Long-term prognostic impact of cystatin c on acute coronary syndrome octogenarians with diabetes mellitus
por: Fu, Zhenhong, et al.
Publicado: (2013)

Corticosteroids significantly increase cystatin C levels in the plasma by promoting cystatin C production in rats
por: Zhu, Xiao-Ran, et al.
Publicado: (2019)

Cystatin C Is Not Causally Related to Coronary Artery Disease
por: Svensson-Färbom, Patrik, et al.
Publicado: (2015)

Prevalence, awareness, treatment and control of diabetes mellitus among middle-aged and elderly people in a rural Chinese population: A cross-sectional study
por: Wang, Qian, et al.
Publicado: (2018)

Peripheral Arterial Disease in Patients with Type 2 Diabetes Mellitus
por: Rhee, Sang Youl, et al.
Publicado: (2015)

Association of Metabolic Obesity Phenotypes and Total Testosterone in Chinese Male Population
por: Liu, Luna, et al.
Publicado: (2021)

Lack of Association between Serum Cystatin C Levels and Coronary Artery Disease in Diabetic Patients
por: Kim, Eun Hee, et al.
Publicado: (2010)

Cystatin C as an Early Biomarker of Nephropathy in Patients with Type 2 Diabetes
por: Jeon, Yun Kyung, et al.
Publicado: (2011)

Diagnostic value of cystatin C for diagnosis of early renal damages in type 2 diabetic mellitus patients: The first experience in Iran
por: Javanmardi, Mitra, et al.
Publicado: (2015)

A clinical observation study on the effect of needle-free insulin syringe on blood glucose control and well-being index in patients with early-onset type 2 diabetes mellitus
por: Jin, Xiaolong, et al.
Publicado: (2023)

Peripheral Artery Disease in Type 2 Diabetes Mellitus: Survival Analysis of an Ecuadorian Population in Primary Care
por: Barrera-Guarderas, Francisco, et al.
Publicado: (2020)

Diabetes Mellitus and Lower Extremity Peripheral Artery Disease
por: Takahara, Mitsuyoshi
Publicado: (2021)

Association of beta-2-microglobulin, cystatin C and lipocalin-2 with stroke risk in the general Chinese population
por: Zhen, Juanying, et al.
Publicado: (2023)

Serum Nesfatin-1 is Reduced in Type 2 Diabetes Mellitus Patients with Peripheral Arterial Disease
por: Ding, Shimei, et al.
Publicado: (2015)

Simple Cystatin C Formula for Estimation of Glomerular Filtration Rate in Overweight Patients with Diabetes Mellitus Type 2 and Chronic Kidney Disease
por: Bevc, Sebastjan, et al.
Publicado: (2012)

Role of cystatin C in renal damage and the optimum cut-off point of renal damage among patients with type 2 diabetes mellitus
por: RAO, XIAOPANG, et al.
Publicado: (2014)

Coronary artery calcium and cystatin C for risk stratification of MACCEs and all‐cause death in symptomatic patients
por: Luo, Fan, et al.
Publicado: (2022)

The Fatty Liver Index, the Strongest Risk Factor for Low Testosterone Level
por: Liu, Luna, et al.
Publicado: (2023)

A New Perspective for Isolated Coronary Artery Ectasia: Cystatin C
por: Karakus, Alper, et al.
Publicado: (2020)

Age and Sex Influence Cystatin C in Adolescents With and Without Type 1 Diabetes
por: Maahs, David M., et al.
Publicado: (2011)

Exercise electrocardiographic responses and serum cystatin C levels among metabolic syndrome patients without overt diabetes mellitus
por: Tanindi, Asli, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_3bvjr6lotnk6var1lgfup1hdr7